Research Use Only. Reference materials for laboratory research — not for human or veterinary use.
Home / Learn / TB-500
Tissue-repair peptide research · 7 articles

TB-500

TB-500 (synthetic thymosin beta-4 fragment 17-23, acetylated) · 6 min read

An introduction to TB-500 as a Thymosin beta-4 fragment reference material used in cytoskeletal research contexts.

What it is

TB-500 is the common designation for a Thymosin beta-4 fragment, supplied as a research-use-only reference peptide. It corresponds to the actin-binding region of the parent Thymosin beta-4 protein and is catalogued under the cytoskeletal research category. Analytical identifiers include CAS number 77591-33-4 and an approximate molecular weight near 4963 g/mol.

Relationship to Thymosin beta-4

Rather than the full protein, TB-500 represents a defined sequence segment associated with actin interaction. This focus on the functional region is what makes it a useful tool compound in studies of cytoskeletal dynamics, where investigators want a tractable peptide reagent rather than the larger native molecule.

Reference framing

As a chemical standard, TB-500 is described by purity, typically not less than 98% by HPLC, and by documented lot data. These descriptors support identity confirmation and batch-to-batch consistency. Everything in this collection concerns analytical identity, handling and the in-vitro research contexts where the peptide is cited.

What follows

Subsequent articles cover the peptide chemistry and stability, the cytoskeletal mechanisms studied in research models, the analytical methods used to verify identity and purity, and a literature survey with search-based sources. The framing stays strictly within laboratory reference-material use.

Documented in every box

Every TB-500 order includes a sealed, lot-controlled vial, the completed lot documentation, and a handling & storage card. Product-specific handling follows the supplied documentation and institutional SOPs.

Evidence limits and research safety

Research findings can differ by model, assay, purity, formulation, and study design. Published cell, biochemical, and pre-clinical observations do not establish human or veterinary safety, efficacy, dosing, or suitability. Researchers should review the applicable SDS, institutional safety procedures, waste requirements, and lot-specific documentation before handling any reference material.

Related research

KLOW Blend · BPC-157 · BPC-157 / TB-500 Blend

Credible sources

Research context only. This article summarizes published in-vitro and pre-clinical research for scientific context. It is not a claim of efficacy or safety and does not constitute medical, usage, or dosing guidance. Get Peptides products are Research Use Only and not for human or veterinary use.

More on TB-500

Chemistry & stability

TB-500: chemistry and laboratory stability

Composition, size and handling considerations for the TB-500 fragment as a research chemical standard.

7 min read
Mechanisms in research

TB-500: cytoskeletal mechanisms in research

The actin-related pathways and assay endpoints that TB-500 is associated with in in-vitro and pre-clinical literature.

7 min read
Analytical characterization

TB-500: identity and purity assessment

Methods used to confirm the identity, purity and lot consistency of TB-500 reference material.

6 min read
Literature & sources

TB-500: research areas and sources

A survey of cytoskeletal research areas where TB-500 appears, with verifiable search sources.

5 min read
Methods note

TB-500: identity review before comparison work

TB-500: identity review before comparison work explains how a laboratory team can frame TB-500 as a characterized research reference for confirming the identity record before comparing a peptide reference across analytical runs. The emphasis is on reproducible preparation, analytical controls, and careful interpretation—not on therapeutic, diagnostic, or in-vivo use.

7 min read
Methods note

TB-500: method-transfer notes

TB-500: method-transfer notes explains how a laboratory team can frame TB-500 as a characterized research reference for recording the evidence needed when a peptide method moves between instruments or analysts. The emphasis is on reproducible preparation, analytical controls, and careful interpretation—not on therapeutic, diagnostic, or in-vivo use.

7 min read